3C-DFE
Overview[edit]
3C-DFE, also known as 3-Chloro-3-deoxyfluoroephedrine, is a synthetic compound that belongs to the class of ephedrine derivatives. It is characterized by the presence of a chlorine atom and a fluorine atom in its molecular structure, which distinguishes it from other ephedrine analogs.
Chemical Properties[edit]
3C-DFE is a chiral compound, meaning it has a specific three-dimensional arrangement that can exist in different stereoisomers. The presence of the chlorine and fluorine atoms in its structure can influence its pharmacokinetics and pharmacodynamics.
Mechanism of Action[edit]
As an ephedrine derivative, 3C-DFE is believed to act primarily as a sympathomimetic agent. It stimulates the release of norepinephrine and dopamine from nerve endings, leading to increased adrenergic receptor activity. This results in effects such as increased heart rate, bronchodilation, and vasoconstriction.
Clinical Applications[edit]
Currently, 3C-DFE is primarily used in research settings to study its effects on the central nervous system and its potential therapeutic applications. Its structural modifications may offer insights into the development of new drugs with improved efficacy and reduced side effects compared to traditional ephedrine.
Safety and Toxicology[edit]
The safety profile of 3C-DFE is not well-established, as it is not widely used in clinical practice. However, as with other sympathomimetic agents, potential side effects may include hypertension, tachycardia, and anxiety. Further studies are needed to fully understand its toxicological properties.
Related Compounds[edit]
3C-DFE is related to other ephedrine derivatives such as pseudoephedrine, methamphetamine, and phenylpropanolamine. These compounds share similar mechanisms of action but differ in their chemical structures and clinical uses.
Research Directions[edit]
Ongoing research is focused on exploring the potential of 3C-DFE in treating conditions such as asthma, narcolepsy, and obesity. Its unique chemical structure may offer advantages over existing treatments, but more studies are needed to confirm its efficacy and safety.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
